PhD Candidates
Lucas Almeida
Lucas develops heat-stable self-amplifying mRNA vaccines suited to low-resource settings, with promising immunogenicity data. His formulation and stability work makes him a strong fit for a vaccine company expanding into emerging markets.
Details
- Advisor
- Dr. Jorge Kalil
- Field
- Vaccine Development
- Institution
- University of São Paulo
- Skills
- mRNA SynthesisLipid Nanoparticle FormulationImmunoassaysCell CultureGMP AwarenessStability Testing
- Thesis
- Self-amplifying mRNA platforms for thermostable tropical-disease vaccines
- Transition Signals
- Internship at a vaccine biotechFiled first patent on a formulationCo-authored with Butantan Institute scientists